这是一篇有关PDGFR alpha的综述,是根据7篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合PDGFR alpha 抗体。
PDGFR alpha 同义词: CD140A; PDGFR-2; PDGFR2; RHEPDGFRA; CD140 antigen-like family member A; CD140a antigen; PDGF-R-alpha; PDGFR-alpha; PDGFRA/BCR fusion; alpha platelet-derived growth factor receptor; alpha-type platelet-derived growth factor receptor; platelet-derived growth factor alpha receptor; platelet-derived growth factor receptor 2; platelet-derived growth factor receptor alpha; rearranged-in-hypereosinophilia-platelet derived growth factor receptor alpha fusion protein

  • 为了研究胶质细胞生存和髓鞘质形成的调节机制,在免疫组织化学试验中使用了R & D Systems的血小板衍生生长因子受体抗体。
  • 为了证明人结肠直肠癌的扩散与PDGFRalpha/beta的表达有直接关系,采用了Santa Cruz Biotechnology的抗PDGFRA抗体进行了免疫印迹和免疫组化实验。
  • 为了检测不同肿瘤样品中的PDGFR alpha,使用了Santa Cruz Biotechnology公司的抗人PDGFR alpha多克隆抗体进行免疫组化实验。
BD Biosciences
  • 为了研究Nkx2.2和Nkx6.2在调节髓鞘形成中的作用,采用了BD公司的鼠抗PDGFRalpha抗体产品(1:300),进行了免疫荧光实验。
  • 为了识别在p53非乳房肿瘤内的一个肿瘤亚群,采用了BD Biosciences的生物素结合的CD140a抗体用在流式细胞试验中。
  • 为了剖析转录因子Olig2以及一些内在的、外在的因素对决定神经细胞的去向所起的作用,使用了BD Biosciences公司的抗PDGFRalpha抗体来进行免疫细胞化学分析。
CARL-HENRIK HELDIN (LUDWIG INSTITUTE FOR CANCER RESEARCH)
  • Dr. Carl-Henrik Heldin (路德维格肿瘤研究所) 血小板源性生长因子受体 alpha 抗体用于免疫组织化学技术来研究卵巢上皮细胞的早期改变和卵巢肿瘤的诱导。
文章列表
  1. Jun Cai et al. (2010). "Co-localization of Nkx6.2 and Nkx2.2 homeodomain proteins in differentiated myelinating oligodendrocytes".PMID 19780200
  2. Mei Zhang et al. (2008). "Identification of tumor-initiating cells in a p53-null mouse model of breast cancer".PMID 18559513
  3. Thomas C Wehler et al. (2008). "PDGFRalpha/beta expression correlates with the metastatic behavior of human colorectal cancer: a possible rationale for a molecular targeting strategy".PMID 18288404
  4. Xinlei Chen et al. (2007). "Early alterations in ovarian surface epithelial cells and induction of ovarian epithelial tumors triggered by loss of FSH receptor".PMID 17603635
  5. Yueting Zhang et al. (2006). "Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation".PMID 17122042
  6. Zhong-Wei Du et al. (2006). "Induced expression of Olig2 is sufficient for oligodendrocyte specification but not for motoneuron specification and astrocyte repression".PMID 17035043
  7. D Ribom et al. (2002). "Prognostic value of platelet derived growth factor alpha receptor expression in grade 2 astrocytomas and oligoastrocytomas".PMID 12023424